These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 9396370)
1. [Effects of low dose methotrexate therapy in rheumatoid arthritis: a comparison of three different dosage regimens]. Totokawa S; Furuya T; Nakajima A; Suzuki T; Kashiwazaki S Ryumachi; 1997 Oct; 37(5):681-7. PubMed ID: 9396370 [TBL] [Abstract][Full Text] [Related]
2. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358 [TBL] [Abstract][Full Text] [Related]
3. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies. Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial. Fleischmann RM; Cohen SB; Moreland LW; Schiff M; Mease PJ; Smith DB; Keenan G; Kremer JM; Curr Med Res Opin; 2005 Aug; 21(8):1181-90. PubMed ID: 16083527 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis]. Gubar' EE; Bochkova AG; Bunchuk NV Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110 [TBL] [Abstract][Full Text] [Related]
7. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study. Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688 [TBL] [Abstract][Full Text] [Related]
8. Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure. Kapral T; Stamm T; Machold KP; Montag K; Smolen JS; Aletaha D Arthritis Res Ther; 2006; 8(2):R46. PubMed ID: 16507172 [TBL] [Abstract][Full Text] [Related]
10. [Combined basic therapy of rheumatoid arthritis with methotrexate and plaquenil]. Sergiets NA; Erov NK Ter Arkh; 2009; 81(6):34-7. PubMed ID: 19663190 [TBL] [Abstract][Full Text] [Related]
11. Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis. Ideguchi H; Ohno S; Ishigatsubo Y J Clin Rheumatol; 2007 Apr; 13(2):73-8. PubMed ID: 17414533 [TBL] [Abstract][Full Text] [Related]
12. [The treatment of rheumatoid arthritis with low dose pulse methotrexate--comparative study with other disease modifying antirheumatic drugs]. Murayama T; Ubukata A; Nakazaki S Ryumachi; 1992 Feb; 32(1):3-11. PubMed ID: 1604414 [TBL] [Abstract][Full Text] [Related]
13. Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate. Wolfe F; Michaud K; Stephenson B; Doyle J J Rheumatol; 2003 Aug; 30(8):1725-32. PubMed ID: 12913927 [TBL] [Abstract][Full Text] [Related]
14. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs. Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314 [TBL] [Abstract][Full Text] [Related]
16. [Clinical relapse of rheumatoid arthritis (escape phenomenon) during low-dose methotrexate therapy]. Suzuki Y; Noguchi A; Tajima C; Uehara R; Ide M; Ichikawa Y; Mizushima Y Ryumachi; 1998 Feb; 38(1):6-13. PubMed ID: 9564772 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic maintenance level of methotrexate in rheumatoid arthritis]. Tahiri L; Allali F; Jroundi I; Abouqal R; Hajjaj-Hassouni N Sante; 2006; 16(3):167-72. PubMed ID: 17284392 [TBL] [Abstract][Full Text] [Related]
18. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial. O'Dell JR; Leff R; Paulsen G; Haire C; Mallek J; Eckhoff PJ; Fernandez A; Blakely K; Wees S; Stoner J; Hadley S; Felt J; Palmer W; Waytz P; Churchill M; Klassen L; Moore G Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219 [TBL] [Abstract][Full Text] [Related]
19. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471 [TBL] [Abstract][Full Text] [Related]
20. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial. Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]